Acute phase reactants in patients with abdominal aortic aneurysm

Atherosclerosis

Volumn 163, Issue 2, 2002, Pages 297-302

  Domanovits, Hans ^a   Schillinger, M ^a   Mullner M ^a   Holzenbein T ^a   Janata, K ^a   Bayegan, K ^a   Laggner, A N ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abdominal aortic aneurysm; CRP; Inflammation; Rupture

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN;

ABDOMINAL AORTA ANEURYSM; AGE; AGED; ANEURYSM RUPTURE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX; STATISTICAL SIGNIFICANCE; SYMPTOM;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; AGED; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE;

EID: 0036277218     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00006-0     Document Type: Article

References (32)

1. New insights into inflammatory aortic aneurysms
2. Inflammatory variant of abdominal aortic atherosclerotic aneurysm
3. Inflammatory abdominal aortic aneurysms: A thirty year review
4. Inflammatory aneurysm of the abdominal aorta: Incidence, pathologic, and etiologic considerations
5. The formation of aneurysms
6. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms
7. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation
8. Inflammatory aneurysms of the abdominal aorta
9. Inflammatory abdominal aortic aneurysms: A review with new perspectives in etiology
10. Suggested standard for reporting on arterial aneurysms
11. Long-term survival in patients undergoing resection of abdominal aortic aneurysm
12. Abdominal aortic aneurysmectomy: A review of 60 consecutive cases contrasting elective and emergency surgery
13. Clinical management of the symptomatic but unruptured abdominal aortic aneurysm
14. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
15. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
16. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
17. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
18. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm
19. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: An immunohistochemical and electron microscopic study
20. Pathogenesis of abdominal aortic aneurysm: An update and look toward the future
21. A review of chlamydia pneumoniae and atherosclerosis
22. Fibrinogen, C-reactive protein, albumin or white cell count: Meta-analyses of prospective studies of coronary heart disease
23. C-reactive protein and risks of future myocardial infarction and thrombotic stroke
24. Inflammation in ischemic heart disease
25. Acute abdominal emergencies in the elderly: Clues to identifying serious illness. Part I - Clinical assessment and diagnostic studies
26. Acute abdominal emergencies in the elderly: Clinical evaluation and management. Part II - Diagnosis and management of common conditions
27. Absence of back pain and tachycardia in the emergency presentation of abdominal aortic aneurysm
28. Unusual manifestations of abdominal aortic aneurysms
29. Indomethacin inhibits expansion of experimental aortic aneurysm via inhibition of the cox2 isoform of cyclooxygenase
30. Pharmacologic suppression of experimental aortic aneurysms: A comparison of doxycycline and four chemically modified tetracyclines
31. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms
32. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications